S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- AVENUE SOLUTIONS
- Client
- MERCK & CO. INC.
- Filing UUID
- 75262fe2-2905-4ed3-8339-c74a1d5094de
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 1672, Maintaining Investments in New Innovation Act; Biosimilars Access and Affordability Act; H.R. 2484, Seniors Access to Critical Medications Act; H.R. 946, ORPHAN Cures Act
Literal federal measure citations: H.R. 1672, H.R. 2484, H.R. 946
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.